CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
10,894,078
Share change
-760,276
Total reported value
$36,384,713
Price per share
$3.34
Number of holders
50
Value change
-$2,370,012
Number of buys
23
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q3 2019

As of 30 Sep 2019, CASI PHARMACEUTICALS INC - COM (CASI) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,894,078 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Wellington Shields Capital Management, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Nuveen Asset Management, LLC, Bank of New York Mellon Corp, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM. This page lists 50 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.